Production (Stage)
iBio, Inc.
IBIO
$1.03
$0.06947.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.22% | -7.40% | -21.03% | -6.32% | -22.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.56% | 2.74% | -20.32% | -27.81% | -41.22% |
| Operating Income | -34.56% | 1.71% | 19.54% | 31.34% | 41.22% |
| Income Before Tax | -84.48% | 2.76% | 21.38% | 34.18% | 58.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -84.48% | 2.76% | 21.38% | 34.18% | 58.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -311.63% | 47.09% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.25% | 46.85% | 30.58% | -28.92% | 56.51% |
| EBIT | -34.56% | 1.71% | 19.54% | 31.34% | 41.22% |
| EBITDA | -38.63% | 0.89% | 19.60% | 32.67% | 43.36% |
| EPS Basic | 42.30% | 89.20% | 90.37% | 87.11% | 92.28% |
| Normalized Basic EPS | 49.65% | 80.24% | 89.09% | 93.42% | 89.56% |
| EPS Diluted | 42.32% | 89.20% | 90.37% | 87.11% | 92.28% |
| Normalized Diluted EPS | 49.65% | 80.24% | 89.09% | 93.42% | 89.56% |
| Average Basic Shares Outstanding | 165.61% | 392.03% | 620.62% | 900.35% | 463.43% |
| Average Diluted Shares Outstanding | 165.61% | 392.03% | 620.62% | 900.35% | 463.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |